• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter regarding the article, "A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients".关于文章《在2型糖尿病高血压患者中，在血管紧张素II受体阻滞剂基础上加用坎利酮与氢氯噻嗪的随机双盲临床试验》的信函
Drug Des Devel Ther. 2019 Jan 21;13:385-386. doi: 10.2147/DDDT.S185297. eCollection 2019.
2
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients.一项在2型糖尿病高血压患者中，比较坎利酮与氢氯噻嗪联合血管紧张素II受体阻滞剂的随机双盲临床试验。
Drug Des Devel Ther. 2018 Aug 24;12:2611-2616. doi: 10.2147/DDDT.S151449. eCollection 2018.
3
Efficacy and safety of two dosages of canrenone as add-on therapy in hypertensive patients taking ace-inhibitors or angiotensin II receptor blockers and hydrochlorothiazide at maximum dosage in a randomized clinical trial: The ESCAPE-IT trial.在一项随机临床试验中，两种剂量的坎利酮作为辅助治疗对正在服用最大剂量血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂及氢氯噻嗪的高血压患者的疗效和安全性：ESCAPE-IT试验
Cardiovasc Ther. 2017 Feb;35(1):47-54. doi: 10.1111/1755-5922.12235.
4
Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.在血压控制不佳的高血压患者中，在现有治疗方案（使用最大耐受剂量的血管紧张素转换酶抑制剂/血管紧张素II 1型受体阻滞剂加氢氯噻嗪）基础上加用坎利酮后的动态血压参数。
Drug Des Devel Ther. 2017 Aug 4;11:2293-2300. doi: 10.2147/DDDT.S134826. eCollection 2017.
5
Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria.缬沙坦/氨氯地平联合治疗控制良好的 2 型糖尿病伴微量白蛋白尿高血压患者中坎利酮或氢氯噻嗪加用的比较效果对尿白蛋白排泄的影响。
Expert Opin Pharmacother. 2014 Mar;15(4):453-9. doi: 10.1517/14656566.2014.874415. Epub 2014 Jan 13.
6
Efficacy of Zofenopril vs. Irbesartan in Combination with a Thiazide Diuretic in Hypertensive Patients with Multiple Risk Factors not Controlled by a Previous Monotherapy: A Review of the Double-Blind, Randomized "Z" Studies.佐芬普利与厄贝沙坦联合噻嗪类利尿剂治疗既往单药治疗未控制的多危险因素高血压患者的疗效：双盲、随机“Z”研究综述
Adv Ther. 2017 Apr;34(4):784-798. doi: 10.1007/s12325-017-0497-8. Epub 2017 Mar 4.
7
Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.以氢氯噻嗪、坎地沙坦或赖诺普利为初始选择的积极降压治疗对II型糖尿病高血压患者白蛋白排泄、内皮功能及炎症的影响：一项双盲随机临床试验
J Hum Hypertens. 2005 Jun;19(6):429-37. doi: 10.1038/sj.jhh.1001812.
8
Valsartan, a new angiotensin II receptor antagonist: a double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide.缬沙坦，一种新型血管紧张素II受体拮抗剂：一项比较缬沙坦与赖诺普利及氢氯噻嗪咳嗽发生率的双盲研究。
J Clin Pharmacol. 1997 Feb;37(2):101-7. doi: 10.1002/j.1552-4604.1997.tb04767.x.
9
Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.奥美沙坦酯氢氯噻嗪复方 40/12.5 毫克治疗中重度高血压患者的疗效和安全性：一项随机、双盲、平行分组、多中心、多国、III 期研究。
Clin Drug Investig. 2010;30(9):581-97. doi: 10.2165/11536710-000000000-00000.
10
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.在高血压未得到控制的糖尿病患者中，将乐卡地平与氢氯噻嗪作为依那普利的附加治疗的疗效和安全性。
J Hypertens. 2006 Jan;24(1):185-92. doi: 10.1097/01.hjh.0000198987.34588.11.

本文引用的文献

1
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients.一项在2型糖尿病高血压患者中，比较坎利酮与氢氯噻嗪联合血管紧张素II受体阻滞剂的随机双盲临床试验。
Drug Des Devel Ther. 2018 Aug 24;12:2611-2616. doi: 10.2147/DDDT.S151449. eCollection 2018.
2
6. Glycemic Targets: .6. 血糖目标： 。
Diabetes Care. 2018 Jan;41(Suppl 1):S55-S64. doi: 10.2337/dc18-S006.
3
Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study.肾素-血管紧张素系统阻断后血清肌酐升高与长期心肾风险：队列研究
BMJ. 2017 Mar 9;356:j791. doi: 10.1136/bmj.j791.
4
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南。
Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27.
5
Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs.醛固酮受体阻滞剂螺内酯和坎利酮：两种多价药物。
Expert Opin Pharmacother. 2014 May;15(7):909-12. doi: 10.1517/14656566.2014.896901. Epub 2014 Mar 11.
6
Choice of diuretic therapy and reconsideration for aldosterone receptors blockers.利尿剂治疗的选择及醛固酮受体阻滞剂的重新审视
Hypertension. 2010 Jan;55(1):e5. doi: 10.1161/HYPERTENSIONAHA.109.147074. Epub 2009 Nov 30.

Letter regarding the article, "A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients".

作者信息

Zhao Ling-Yue, Luo Yi-Jun, Zhu Jing

机构信息

Department of Ambulatory Surgery, Shenzhen Nanshan District People's Hospital, Shenzhen, Guangdong 518052, People's Republic of China,

出版信息

Drug Des Devel Ther. 2019 Jan 21;13:385-386. doi: 10.2147/DDDT.S185297. eCollection 2019.

DOI:10.2147/DDDT.S185297
PMID:30718943
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6345323/
Abstract
摘要